SinoNasal Microbiota Transfer to treat recalcitrant chronic rhinosinusitis: A case series
Key Points
SinoNasal Microbiota Transfer (SNMT) was safe with immediate benefit in all recipients, with sustained improvement in two of three recipients for up to 180 days.
The addition of antimicrobial photodynamic therapy worsened chronic rhinosinusitis.
These promising SNMT results warrant further study of safety and efficacy.
Source: International Forum of Allergy and Rhinology - Category: Allergy & Immunology Authors: Sandeep K. Gill,
Juan C. Hernaiz ‐Leonardo,
Thaddeus J. Edens,
Athenea Pascual,
Chris Tang,
Judy Fan,
Andrew Thamboo,
Warren Mullings,
Saad Alsaleh,
Bader M. Alim,
Amin R. Javer,
Amee R. Manges Tags: RESEARCH NOTE Source Type: research
MedWorm Privacy Policy
Disclaimer
Copyright © MedWorm 2006-2024